Arch Biopartners Adds Three New Clinical Sites into the

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that...

Related Keywords

Istanbul ,Turkey ,Toronto ,Ontario ,Canada ,United States ,Ankara ,United Kingdom ,Canadian ,British ,Stephen Robbins ,University Hospital ,Arch Biopartners Inc ,Gazi University Hospital ,Istanbul University ,Biopartners Inc ,Istanbul University Cerrahpa ,Kidney Disease ,Improving Global Outcomes ,Video Link ,Science Advances ,Placebo Controlled Study ,Acute Kidney Injury ,Patients Undergoing On Pump Cardiac ,Donna Senger ,British Medical Journal Open ,Arch Biopartner ,Canadian Securities Administrator System ,Electronic Document Analysis ,Tsx Venture Exchange Arch ,Arch Biopartners ,S Aki ,Phase Ii Trial ,Alexion ,Oche ,Kidney Foundation ,Revent Kidney Failure ,Salt ,Novo Nordisk ,Nflammation Drug ,Rch Bio ,Biotech ,